Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Eur J Cancer. 2015 Aug 19;51(16):2413–2422. doi: 10.1016/j.ejca.2015.06.109

Table 4.

Univariate analysis of recurrence-free survival (RFS) for patients with localised disease.

Number of patients Number of events Median RFS 5-year RFS P-value
Histology
 FDCS 23 16 2.86 0.34
 HS   6   2 NR* 0.67 0.49
 IDCS   5   2 NR 0.6
*

NR: not reached FDCS, follicular dendritic cell sarcoma; HS, histiocytic sarcoma; IDCS, interdigitating dendritic cell sarcoma; CNS, central nervous system.